Compile Data Set for Download or QSAR
maximum 50k data
Found 18 Enz. Inhib. hit(s) with all data for entry = 6728
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150179(US8980904, 4)
Affinity DataIC50:  0.0280nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150181(US8980904, 6)
Affinity DataIC50:  0.0750nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150178(US8980904, 3)
Affinity DataIC50:  0.100nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150190(US8980904, 15)
Affinity DataIC50:  0.119nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150176(US8980904, 1)
Affinity DataIC50:  0.172nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150184(US8980904, 9)
Affinity DataIC50:  0.186nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150188(US8980904, 13)
Affinity DataIC50:  0.213nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150183(US8980904, 8)
Affinity DataIC50:  0.476nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150180(US8980904, 5)
Affinity DataIC50:  0.529nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150187(US8980904, 12)
Affinity DataIC50:  0.719nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150182(US8980904, 7)
Affinity DataIC50:  0.739nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150186(US8980904, 11)
Affinity DataIC50:  0.935nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150185(US8980904, 10)
Affinity DataIC50:  1.14nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150192(US8980904, 18)
Affinity DataIC50:  1.44nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150189(US8980904, 14)
Affinity DataIC50:  1.98nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150191(US8980904, 17)
Affinity DataIC50:  2.08nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150177(US8980904, 2)
Affinity DataIC50:  4.01nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Xuanzhu Pharma

US Patent
LigandPNGBDBM150193(US8980904, 19)
Affinity DataIC50:  4.08nMpH: 7.5 T: 2°CAssay Description:A sample to be tested is precisely weighed, dissolved by adding DMSO, mixed sufficiently to form 10 mM solution. The above mother solution is diluted...More data for this Ligand-Target Pair
In DepthDetails US Patent